We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 17, 2020

FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers

JAMA Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial
JAMA Oncol 2020 May 29;[EPub Ahead of Print], H Park, RU Jin, A Wang-Gillam, R Suresh, C Rigden, M Amin, BR Tan, KS Pedersen, KH Lim, NA Trikalinos, A Acharya, ML Copsey, KA Navo, AE Morton, F Gao, AC Lockhart

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading